Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P65
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 7.91% |
| Q3 2025 | -20.29% |
| Q2 2025 | 36.58% |
| Q1 2025 | 32.52% |
| Q4 2024 | -42.06% |
| Q3 2024 | 37.68% |
| Q2 2024 | -11890.83% |
| Q1 2024 | -104.21% |
| Q4 2023 | 338.78% |
| Q3 2023 | -166.33% |
| Q2 2023 | 256.54% |
| Q1 2023 | 89.42% |
| Q4 2022 | -15.57% |
| Q3 2022 | 8.47% |
| Q2 2022 | -16.09% |
| Q1 2022 | -44.13% |
| Q4 2021 | -35.27% |
| Q3 2021 | -61.09% |
| Q2 2021 | -3.08% |
| Q1 2021 | -40.03% |
| Q4 2020 | 0.00% |